In the current investigation, MKRN1 was discovered to be substantially expressed in CRC and that high MKRN1 promoted CRC progression through EMT induction, a function mainly achieved through MKRN1 ubiquitination and degradation of SNIP1, thereby activating the TGF-β pathway. This evidence concerns the gene MKRN1 and colorectal carcinoma.